about
Bacteria-human somatic cell lateral gene transfer is enriched in cancer samplesA review of bacteria-animal lateral gene transfer may inform our understanding of diseases like cancerVaccination of cattle with a CpG oligodeoxynucleotide-formulated mycobacterial protein vaccine and Mycobacterium bovis BCG induces levels of protection against bovine tuberculosis superior to those induced by vaccination with BCG alone.Attenuation of Innate Immunity by Andrographolide Derivatives Through NF-κB Signaling Pathway.An antimicrobial peptide regulates tumor-associated macrophage trafficking via the chemokine receptor CCR2, a model for tumorigenesis.Mobile elements and viral integrations prompt considerations for bacterial DNA integration as a novel carcinogenCpG DNA modulates interleukin 1beta-induced interleukin-8 expression in human bronchial epithelial (16HBE14o-) cells.Role of innate immunity in the pathogenesis of otitis mediaThe Characterization of Novel Tissue Microbiota Using an Optimized 16S Metagenomic Sequencing Pipeline.Modulation of Innate Immune Responses via Covalently Linked TLR Agonists.Immunization against the transgene but not the TetON switch reduces expression from gutless adenoviral vectors in the brain.Review: Enthesitis: New Insights Into Pathogenesis, Diagnostic Modalities, and Treatment.Synthetic adjuvants for vaccine formulations: phytol derivatives.Friendly pathogens: prevent or provoke autoimmunity.Advances in Toll-like receptor biology: Modes of activation by diverse stimuli.Extracellular poly(ADP-ribose) is a pro-inflammatory signal for macrophages.Impact of viral and host DNA methylations on HPV16-related cervical cancer pathogenesis.In vitro and in vivo evaluations of human papillomavirus type 16 (HPV16)-derived peptide-loaded dendritic cells (DCs) with a CpG oligodeoxynucleotide (CpG-ODN) adjuvant as tumor vaccines for immunotherapy of cervical cancer.Efficacy of different carriers for the triple antibiotic powder during regenerative endodontic procedures.Danger signals in trauma.
P2860
Q21090158-1C31C56E-1501-4E76-9CFD-E4B84769CC19Q26864092-360B5E6A-F1E6-42EE-AB38-DD9992AFB197Q33788201-52C7DF85-2928-4596-8417-4571A3BAF8B3Q33875293-7E0C8122-DDF4-423E-B25B-76F873943AAAQ33900352-C0E99DC7-E173-4202-95FC-2527D8C15DF5Q34053726-47632893-7BD0-4980-A9DE-EF826F458A59Q34722393-0B883DFF-F899-4365-B4E0-CF63E9CE2EB6Q35027403-7F05A138-35C7-4671-8AAC-2D6E210C962AQ36257713-880E9E09-157D-4453-AD35-AE43A19259CDQ36333881-FBCE138A-2C55-439D-8429-7E7C9FECEF18Q37245006-CB86C8DC-F10E-4BE5-9998-67F8358496ECQ37541327-031145CC-6297-427A-A002-74BF6C1CACE4Q38072067-BE0A2791-6E05-4227-BF2F-003E4F07DF99Q38108013-91EADED6-CA8B-4E49-A9DE-F26CBDB02DD0Q38413291-60818E44-2165-4B1C-80AE-8D2C7596444EQ38888354-84AD0BE5-0ABA-479B-A276-EDA4CDAAAA34Q40220618-FDC8DE3D-AAA0-4AB7-A27A-E43893FB00E3Q42279298-40ECAB9A-DBB5-44BF-A1ED-E6F61BCD4C8AQ47442398-50A21198-DA4F-49E4-B615-9632396D41C1Q55355541-57CCD7F8-ECF5-4797-AC34-86C2323F5808
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Activation of the immune system by bacterial CpG-DNA.
@ast
Activation of the immune system by bacterial CpG-DNA.
@en
Activation of the immune system by bacterial CpG-DNA.
@nl
type
label
Activation of the immune system by bacterial CpG-DNA.
@ast
Activation of the immune system by bacterial CpG-DNA.
@en
Activation of the immune system by bacterial CpG-DNA.
@nl
prefLabel
Activation of the immune system by bacterial CpG-DNA.
@ast
Activation of the immune system by bacterial CpG-DNA.
@en
Activation of the immune system by bacterial CpG-DNA.
@nl
P2093
P2860
P1433
P1476
Activation of the immune system by bacterial CpG-DNA.
@en
P2093
Georg Häcker
Hans Häcker
Vanessa Redecke
P2860
P304
P356
10.1046/J.0019-2805.2001.01350.X
P577
2002-03-01T00:00:00Z